SHANGHAI, April 22, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter of 2014 after the New York Stock Exchange closes on Wednesday, May 14, 2014 (which will be Thursday morning, May 15, 2014 Shanghai time). The earnings release will be available on the investor relations section of the Company's website at http://www.wuxiapptec.com/.
Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing / Shanghai / Hong Kong) on Thursday, May 15, 2014, to discuss the first-quarter 2014 financial results and recent business activities. The conference call may be accessed by calling:
4001 200 539
800 905 927
800 616 3222
0800 015 9725
1855 298 3404
United States -- New York (toll)
+1 631 5142 526
Other countries (toll)
+65 6823 2299
A telephone replay will be availabletwo hours after the call's completion at:
4001 842 240
800 966 697
800 616 2127
0800 169 7301
1866 846 0868
A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com/.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology, and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.
For more information, please contact:
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
SOURCE WuXi PharmaTech (Cayman) Inc.